Market Overview:
The global mice model market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing use of mice models in research and drug discovery, technological advancements in mouse modeling, and rising demand for genetically modified mice models. However, the high cost of mouse models is restraining the growth of this market. Based on type, the global mice model market can be segmented into inbred, knockout, and hybrid mice models. Inbred mouse models are dominating the global market due to their low cost and easy availability. However, knockout mouse models are expected to grow at a higher CAGR during the forecast period as they are used extensively for studying gene function and protein interactions.
Product Definition:
A mice model is a representation of the real world, used in scientific experiments and mathematical simulations. The purpose of using a mice model is to help researchers understand how things work in the real world by studying them under controlled conditions.
Inbred:
Inbred mice are genetically similar variants with uniformity as their parents and offspring. They have a high incidence rate of genetic disorders, which is expected to accelerate the need for research on these models. Inbred mice are preferred over outbred ones due to their close resemblance to human beings making them easier and more effective in finding solutions for medical conditions related to genetics such as diabetes, cardiovascular diseases, etc.
Knockout:
Knockout is a method used to determine the effect of a particular drug by eliminating one or more genes from an organism. The most commonly used animal models for human disease are mice. Mice are genetically modified so that they can be studied for human diseases as they have similar biology as humans. They also serve as excellent research tools since they are available in large numbers and can be studied extensively using various techniques such as behavioral testing, gene targeting, etc.
Application Insights:
The other application segment accounted for the largest share of more than 50.0% in 2017. The use of mice models to study various diseases, such as autoimmune disease, neurological disorders and cancer is anticipated to fuel the segment growth over the forecast period. For instance, researchers have developed a new type of mouse model that can mimic human autoimmune conditions by producing high levels of inflammatory cytokines in the body¢â‚¬â„¢s immune system cells (T-cells). This has led to advancements in understanding these disorders and developing effective treatment options for them (Ref).
In addition, several research initiatives are being taken by governments worldwide to standardize animal models used for drug testing purposes so that they can be used across different industries and regulated bodies (e.g., FDA) have made efforts towards this end with an aim toward improving patient safety & wellness globally (Ref).
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare facilities and highly developed research infrastructure in this region is likely to boost the growth of this industry. Moreover, increasing government funding for cancer research and rising prevalence of chronic diseases are also expected to drive regional market growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to untapped opportunities in this region. Japan, China, India have a large number of patients suffering from various types of cancers; however, they do not perform animal testing due to lack of awareness or because it is considered barbaric by westerners’ standards thus resulting into huge potential for revenue generation in Asia Pacific region especially in developing countries such as India and China which has a high population density with low per capita income but high GDP Growth Rate (GDP per person).
Growth Factors:
- Increasing demand for personalized medicines and regenerative therapies
- Rising prevalence of chronic diseases such as cancer, diabetes, and heart diseases
- Growing number of preclinical studies and clinical trials to assess the safety and efficacy of new drugs
- Technological advancements in mouse models that are helping researchers to study complex diseases more effectively
- Increasing investments by pharmaceutical companies in research and development
Scope Of The Report
Report Attributes
Report Details
Report Title
Mice Model Market Research Report
By Type
Inbred, Knockout, Hybrid
By Application
Cancer Research, Inflammation Of The Research, Diabetes Research, Cardiovascular Disease Research, Other
By Companies
Charles River Laboratories International, The Jackson Laboratory, Taconic Biosciences, Envigo, Laboratory Corporation Of America Holdings, Janvier Labs, Harbour Antibodies, Trans Genic, Genoway, Horizon Discovery, Ingenious Targeting Laboratory
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Mice Model Market Report Segments:
The global Mice Model market is segmented on the basis of:
Types
Inbred, Knockout, Hybrid
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer Research, Inflammation Of The Research, Diabetes Research, Cardiovascular Disease Research, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Charles River Laboratories International
- The Jackson Laboratory
- Taconic Biosciences
- Envigo
- Laboratory Corporation Of America Holdings
- Janvier Labs
- Harbour Antibodies
- Trans Genic
- Genoway
- Horizon Discovery
- Ingenious Targeting Laboratory
Highlights of The Mice Model Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Inbred
- Knockout
- Hybrid
- By Application:
- Cancer Research
- Inflammation Of The Research
- Diabetes Research
- Cardiovascular Disease Research
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mice Model Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A mouse model is a system that mimics the natural behavior of a living organism in order to study how that organism functions.
Some of the key players operating in the mice model market are Charles River Laboratories International, The Jackson Laboratory, Taconic Biosciences, Envigo, Laboratory Corporation Of America Holdings, Janvier Labs, Harbour Antibodies, Trans Genic, Genoway, Horizon Discovery, Ingenious Targeting Laboratory.
The mice model market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Mice Model Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Mice Model Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Mice Model Market - Supply Chain
4.5. Global Mice Model Market Forecast
4.5.1. Mice Model Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Mice Model Market Size (000 Units) and Y-o-Y Growth
4.5.3. Mice Model Market Absolute $ Opportunity
5. Global Mice Model Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Mice Model Market Size and Volume Forecast by Type
5.3.1. Inbred
5.3.2. Knockout
5.3.3. Hybrid
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Mice Model Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Mice Model Market Size and Volume Forecast by Application
6.3.1. Cancer Research
6.3.2. Inflammation Of The Research
6.3.3. Diabetes Research
6.3.4. Cardiovascular Disease Research
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Mice Model Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Mice Model Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Mice Model Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Mice Model Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Mice Model Demand Share Forecast, 2019-2029
9. North America Mice Model Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Mice Model Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Mice Model Market Size and Volume Forecast by Application
9.4.1. Cancer Research
9.4.2. Inflammation Of The Research
9.4.3. Diabetes Research
9.4.4. Cardiovascular Disease Research
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Mice Model Market Size and Volume Forecast by Type
9.7.1. Inbred
9.7.2. Knockout
9.7.3. Hybrid
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Mice Model Demand Share Forecast, 2019-2029
10. Latin America Mice Model Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Mice Model Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Mice Model Market Size and Volume Forecast by Application
10.4.1. Cancer Research
10.4.2. Inflammation Of The Research
10.4.3. Diabetes Research
10.4.4. Cardiovascular Disease Research
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Mice Model Market Size and Volume Forecast by Type
10.7.1. Inbred
10.7.2. Knockout
10.7.3. Hybrid
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Mice Model Demand Share Forecast, 2019-2029
11. Europe Mice Model Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Mice Model Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Mice Model Market Size and Volume Forecast by Application
11.4.1. Cancer Research
11.4.2. Inflammation Of The Research
11.4.3. Diabetes Research
11.4.4. Cardiovascular Disease Research
11.4.5. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Mice Model Market Size and Volume Forecast by Type
11.7.1. Inbred
11.7.2. Knockout
11.7.3. Hybrid
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Mice Model Demand Share, 2019-2029
12. Asia Pacific Mice Model Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Mice Model Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Mice Model Market Size and Volume Forecast by Application
12.4.1. Cancer Research
12.4.2. Inflammation Of The Research
12.4.3. Diabetes Research
12.4.4. Cardiovascular Disease Research
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Mice Model Market Size and Volume Forecast by Type
12.7.1. Inbred
12.7.2. Knockout
12.7.3. Hybrid
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Mice Model Demand Share, 2019-2029
13. Middle East & Africa Mice Model Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Mice Model Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Mice Model Market Size and Volume Forecast by Application
13.4.1. Cancer Research
13.4.2. Inflammation Of The Research
13.4.3. Diabetes Research
13.4.4. Cardiovascular Disease Research
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Mice Model Market Size and Volume Forecast by Type
13.7.1. Inbred
13.7.2. Knockout
13.7.3. Hybrid
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Mice Model Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Mice Model Market: Market Share Analysis
14.2. Mice Model Distributors and Customers
14.3. Mice Model Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Charles River Laboratories International
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. The Jackson Laboratory
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Taconic Biosciences
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Envigo
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Laboratory Corporation Of America Holdings
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Janvier Labs
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Harbour Antibodies
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Trans Genic
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Genoway
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Horizon Discovery
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Ingenious Targeting Laboratory
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
